Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
February 23, 2021
Three-dimensional structure of human cyclooxygenase (hCOX)-1
Morena Miciaccia, Benny Danilo Belviso, Mariaclara Iaselli, et al.
Food Research International (Ottawa, Ont.)
|
November 21, 2023
Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake
Paola Foti, Cinzia L Randazzo, Mariateresa Russo, et al.
European Journal of Medicinal Chemistry
|
June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection
Antonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 27, 2025
Exosomes in Ovarian Cancer: Towards Precision Oncology
Maria Grazia Perrone, Silvana Filieri, Amalia Azzariti, et al.
Molecules (Basel, Switzerland)
|
July 29, 2023
<i>m</i>-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity
Damiano Rocchi, Juan F González, Olmo Martín-Cámara, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 24, 2022
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes
Maria Grazia Perrone, Paola Vitale, Morena Miciaccia, et al.
ACS Applied Materials & Interfaces
|
December 11, 2025
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood-Brain Barrier Permeability and Neuroprotective Chelation Therapy
Mónica Onrubia-Márquez, Francisco Navas, Esther M Sánchez-Carnerero, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design
Lukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Frontiers in Oncology
|
March 6, 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Annalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.
European Journal of Medicinal Chemistry
|
January 14, 2024
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior
Roberta Solidoro, Morena Miciaccia, Carmela Bonaccorso, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
February 23, 2021
Three-dimensional structure of human cyclooxygenase (hCOX)-1
Morena Miciaccia, Benny Danilo Belviso, Mariaclara Iaselli, et al.
Food Research International (Ottawa, Ont.)
|
November 21, 2023
Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake
Paola Foti, Cinzia L Randazzo, Mariateresa Russo, et al.
European Journal of Medicinal Chemistry
|
June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection
Antonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 27, 2025
Exosomes in Ovarian Cancer: Towards Precision Oncology
Maria Grazia Perrone, Silvana Filieri, Amalia Azzariti, et al.
Molecules (Basel, Switzerland)
|
July 29, 2023
<i>m</i>-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity
Damiano Rocchi, Juan F González, Olmo Martín-Cámara, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 24, 2022
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes
Maria Grazia Perrone, Paola Vitale, Morena Miciaccia, et al.
ACS Applied Materials & Interfaces
|
December 11, 2025
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood-Brain Barrier Permeability and Neuroprotective Chelation Therapy
Mónica Onrubia-Márquez, Francisco Navas, Esther M Sánchez-Carnerero, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design
Lukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Frontiers in Oncology
|
March 6, 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Annalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.
European Journal of Medicinal Chemistry
|
January 14, 2024
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior
Roberta Solidoro, Morena Miciaccia, Carmela Bonaccorso, et al.
Page
of 3